Hirasawa Takeshi

ヒラサワタケシ | Hirasawa Takeshi

Affiliation and department：
Research theme for competitive and other funds (7)：

2020 - 2024 既成概念を打破する血清網羅的糖ペプチド解析による卵巣癌早期診断の社会実装
2018 - 2021 Development of hemodiagnosis for early detection of ovarian cancer with AI using glycopeptide peaks obtained from CSGSA (Comprehensive Serum Glycopeptide Spectra Analysis)
2018 - 2021 The vaginal microbiome in pathogenesis of endometriosis and endometriosis-related ovarian cancer
2017 - 2021 Development of hemodiagnosis for early detection of ovarian cancer using glycopeptide peaks obtained from CSGSA (Comprehensive Serum Glycopeptide Spectra Analysis)
2011 - 2013 Drug discovery and a new carcinogenic process in the clear cell adenocarcinoma of uterine body

Show all

Papers (474)：

Daisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, Toshiaki Nakamura, Eiji Kondo, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, et al. Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study. Journal of gynecologic oncology. 2024. 35. 5. e114
Hiroko Machida, Koji Matsuo, Masayuki Tanaka, Kanae Kitatani, Akinori Takase, Keiko Yokoyama, Hiroshi Kajiwara, Miwa Yasaka, Masae Ikeda, Hiroshi Yoshida, et al. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology. 2023. 171. 59-66
Masae Ikeda, Miwa Yasaka, Tetsuji Iida, Masako Shida, Hiroshi Yoshida, Takeshi Hirasawa, Mikio Mikami. Pyogenic Spondylitis in Multidisciplinary Therapies of Gynecologic Malignancies: Three Cases Reports. The Tokai journal of experimental and clinical medicine. 2021. 46. 2. 118-122
磯崎太一, 沼崎令子, 新井努, ルイズ横田奈朋, 吉田浩, 杉浦賢, 大原樹, 高田恭臣, 木挽貢慈, 佐々木康, et al. 令和元年度神奈川県産科婦人科医会婦人科悪性腫瘍登録集計報告. 神奈川産科婦人科学会誌. 2021. 57. 2. 190-190
Aikou Okamoto, Eiji Kondo, Toshiaki Nakamura, Satoshi Yanagida, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, Shinichi Komiyama, et al. Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer. Journal of gynecologic oncology. 2021. 32. 2. e16

ｍore...

MISC (31)：

中村俊昭, 田畑務, 柳田聡, 近藤英司, 濱西潤三, 原野謙一, 長谷川幸清, 平澤猛, 堀謙輔, 小宮山慎一, et al. 前治療歴を有する高悪性度漿液性卵巣癌患者を対象としたニラパリブの国内第II相臨床試験の最終結果(The Final Results of a Japanese Phase 2 Study of Niraparib in Heavily Pretreated, HRd High-grade Serous Ovarian Cancer Patients). 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 193-193
矢島優希, 矢坂美和, 百瀬浩晃, 飯田哲士, 池田仁惠, 吉田浩, 平澤猛, 三上幹男, 石本人士. 子宮腺筋症から発生した子宮癌肉腫の一例. 関東連合産科婦人科学会誌. 2021. 58. 3. 395-395
樽見知奈美, 矢坂美和, 義澤航平, 岡宮稜子, 百瀬浩晃, 飯田哲士, 池田仁恵, 信田政子, 吉田浩, 平澤猛, et al. 卵巣癌との鑑別が困難であった後腹膜軟部肉腫の1例. 神奈川産科婦人科学会誌. 2021. 58. 1. 115-115
百瀬浩晃, 吉田浩, 矢坂美和, 飯田哲士, 池田仁惠, 平澤猛, 三上幹男. 肥満を合併した子宮体癌患者に対する傍大動脈リンパ節摘出を伴った腹腔鏡下手術(Laparoscopic surgery including para-aortic lymphadenectomy for endometrial cancer with obesity). 日本産科婦人科内視鏡学会雑誌. 2021. 37. Suppl.I. 330-330
樽見知奈美, 矢坂美和, 義澤航平, 岡宮稜子, 百瀬浩晃, 飯田哲士, 池田仁恵, 信田政子, 吉田浩, 平澤猛, et al. 卵巣癌との鑑別が困難であった後腹膜軟部肉腫の一例. 神奈川医学会雑誌. 2021. 48. 2. 47-47

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page